Drug Search Results
More Filters [+]

Cotinine

Alternative Names: cotinine
Latest Update: 2023-10-04
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Inhalant

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Institute on Drug Abuse (NIDA)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cotinine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Chronic Pain|Acute Pain

Phase 2: Tobacco Use Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT04274673

P4

Unknown status

Acute Pain|Chronic Pain

2020-05-13

NCT03062709

N/A

Completed

Bronchopulmonary Dysplasia|Tobacco Use Disorder|Smoking Cessation|Bronchiolitis|Asthma|Pneumonia

2017-03-30

SCUSF 1201

P2

Withdrawn

Tobacco Use Disorder

2016-06-01

R01HL066307

N/A

Completed

Asthma

2008-01-01

Recent News Events